Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/49360
Title: One-versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programme
Authors: Oliva, A
Angiolillo, DJ
Valgimigli, M
Cao, D
Sartori, S
Bangalore, S
Bhatt, DL
Campo, G
Chehab, BM
Choi, JW
Hernandez, JMD
Feng, YH
Ge, JB
Gitto, M
Hermiller, J
Krucoff, MW
Kunadian, V
Makkar, RR
Maksoud, A
Neumann, FJ
Picon, H
Saito, S
Sardella, G
Thiele, H
Toelg, R
Varenne, O
Vogel, B
VRANCKX, Pascal 
Windecker, S
Mehran, R
Issue Date: 2025
Publisher: EUROPA EDITION
Source: EUROINTERVENTION, 21 (12) , p. e668 -e680
Abstract: In patients with diabetes mellitus (DM) and high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI), the optimal duration of dual antiplatelet therapy (DAPT) remains uncertain.
Keywords: bleeding;DAPT;diabetes;high bleeding risk;percutaneous coronary intervention
Document URI: http://hdl.handle.net/1942/49360
ISSN: 1774-024X
e-ISSN: 1969-6213
DOI: 10.4244/EIJ-D-24-00897
ISI #: 001520525800003
Rights: Europa Group 2025. All rights reserved.
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
106_EIJ-D-24-00897_Oliva.pdf
  Restricted Access
Published version1.94 MBAdobe PDFView/Open    Request a copy
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.